Public Comments submitted: VolREthics initiative Global Ethics Charter for the Protection of Healthy Volunteers in Clinical Trials March 30, 2024
However, because it affects weight, insulin, and metabolism, it can lead to indirect hormonal changes
The treatment diminished triacylglycerol in muscle and plasma, decreased hepatic steatosis, and normalized CPT1, improving ACC and fatty acid synthase [86]
"Patients are willing to do anything to get their hands on this product, and they're risking their lives," she said
At 80 weeks, results showed that all three doses of retatrutide met the primary and key secondary end points for obesity, with clinically meaningful weight loss in all three groups